Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Harald E. Vonkeman"'
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 6, Pp n/a-n/a (2022)
Abstract The objective of this study was to examine the maintenance of effect and safety after a hospital‐wide switch for economic reasons from adalimumab originator Humira® to biosimilar Amgevita® in real‐world rheumatoid arthritis (RA) patien
Externí odkaz:
https://doaj.org/article/3d79bf2249de4c7e9871e00ca2295bf1
Autor:
Caroline B. Terwee, Marloes Zuidgeest, Harald E. Vonkeman, David Cella, Lotte Haverman, Leo D. Roorda
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background The International Consortium for Health Outcomes Measurement (ICHOM) develops condition-specific Standard Sets of outcomes to be measured in clinical practice for value-based healthcare evaluation. Standard Sets are developed by d
Externí odkaz:
https://doaj.org/article/0b4ca8f97f904b408add44535e5f3b1e
Autor:
Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J. Bernelot Moens, Henk Visser, Annemarie M. Schilder, Marc R. Kok, Robert B. M. Landewé, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Tim L. Jansen, on behalf of the Dutch National POET Collaboration
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)
Abstract Background The aim of this study was to identify predictors of prolonged disease control after discontinuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA). Methods Post-hoc analysis of 439 R
Externí odkaz:
https://doaj.org/article/ddbedcb42a224131ae7c3a0b9702e2e3
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-9 (2019)
Abstract Background Adjusting medication of patients with rheumatoid arthritis (RA) until predefined disease activity targets are met, i.e. Treat-to-Target (T2T), is the currently recommended treatment approach. However, not much is known about long-
Externí odkaz:
https://doaj.org/article/a03dcea431ce4b3a9b74a8a78fcdcbf2
Autor:
Carly A. Janssen, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim L. Th. A. Jansen, Harald E. Vonkeman, Mart A. F. J. van de Laar
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background Gout is a common, monosodium urate crystal-driven inflammatory arthritis. Besides its clinical manifestations, patients often also suffer from pain, physical impairment, emotional distress and work productivity loss, as a result o
Externí odkaz:
https://doaj.org/article/989dc2f159554869b5de652b11fadf22
Autor:
Laura M. M. Steunebrink, Letty G. A. Versteeg, Harald E. Vonkeman, Peter M. ten Klooster, Monique Hoekstra, Mart A. F. J. van de Laar
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-10 (2018)
Abstract Background Early and intensive targeted treatment with disease modifying anti-rheumatic drugs (DMARDs) has been shown to lead to substantial reductions in disease activity and radiograph damage in patients with early rheumatoid arthritis (RA
Externí odkaz:
https://doaj.org/article/585ac666ac81420ea90fb34656e2dc38
Autor:
Ingrid Nota, Constance H. C. Drossaert, Heleen C. Melissant, Erik Taal, Harald E. Vonkeman, Cees J. Haagsma, Mart A. F. J. van de Laar
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background A main element of patient-centred care, Patient Decision Aids (PtDAs) facilitate shared decision-making (SDM). A recent update of the International Patient Decision Aids Standards (IPDAS) emphasised patient involvement during PtDA
Externí odkaz:
https://doaj.org/article/81375992dc094221a0713c961baa182f
Publikováno v:
Pharmaceuticals, Vol 3, Iss 7, Pp 2146-2162 (2010)
While aspirin may offer protection, other non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) can cause serious cardiovascular side effects and complications. This has led to a general "black box" warning for cardiovascular adverse events for
Externí odkaz:
https://doaj.org/article/6e94f9bf0a9f40e38f1cd9a4a48b481b
Autor:
Carlomaurizio Montecucco, Rieke Alten, Robert Moots, Peggy Jacques, Helga Radner, Harald E Vonkeman, Nicolas Krucien, Sebastian Heidenreich, Katrien Van Beneden, Juan Carlos Nieto-González, Chiara Whichello
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objective Understanding preferences of patients with rheumatoid arthritis (RA) can facilitate tailored patient-centric care. This study elicited trade-offs that patients with RA were willing to make during treatment selection.Methods Patients with RA
Externí odkaz:
https://doaj.org/article/055575b73ad9497386ed521caaa9b66b
Autor:
Pim A de Jong, Marloes W Heijstek, Julia Spierings, Karijn P M Suijkerbuijk, Nienke J Kleinrensink, Wouter Foppen, Harald E Vonkeman, Mylène P Jansen, Negina Seddiqi, Amin Herman
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Background Patients with psoriatic arthritis (PsA) have an increased risk of cardiovascular disease, possibly due to a chronic inflammatory state.Objectives The main objective of this study was to investigate the difference in vascular inflammation,
Externí odkaz:
https://doaj.org/article/ef48fea1ca8e4124b57f1f9e74d1a5f3